Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2019;16:535–48. https://doi.org/10.1038/s41571-019-0194-4.
CAS Article PubMed Google Scholar
Chan AM, Baehring JM. Paraneoplastic neurological syndromes: a single institution 10-year case series. J Neurooncol. 2019;141:431–9. https://doi.org/10.1007/s11060-018-03053-3.
Lorusso L, Precone V, Hart IK, Giometto B, Pezzani R, Ngonga GK, et al. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study. J Biosci. 2021;46:13. https://doi.org/10.1007/s12038-020-00128-0.
CAS Article PubMed Google Scholar
Hébert J, Riche B, Vogrig A, Muñiz-Castrillo S, Joubert B, Picard G, et al. Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France. Neurol Neuroimmunol neuroinflammation. 2020;7: e883. https://doi.org/10.1212/NXI.0000000000000883.
Lorusso L, Precone V, Ferrari D, Ngonga GK, Russo AG, Paolacci S, et al. Paraneoplastic neurological syndromes: study of prevalence in a province of the Lombardy region Italy. J Clin Med. 2020;9:1–8. https://doi.org/10.3390/jcm9103105.
Corsellis JAN, Goldberg GJ, Norton AR. ‘Limbic encephalitis’ and its association with carcinoma. Brain. 1968;91:481–96. https://doi.org/10.1093/brain/91.3.481.
CAS Article PubMed Google Scholar
Graus F, Cordon-Cardo C, Posner JB, F G, C C-C, and JB P. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 1985; 35: 538–43. https://doi.org/10.1212/wnl.35.4.538.
Graus F, Vogrig A, Muñiz-Castrillo S, Antoine J-CGCG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflammation 2021; 8: e1014. https://doi.org/10.1212/NXI.0000000000001014. Important paper revising the old criteria for paraneoplastic neurologic syndromes.
Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36. https://doi.org/10.1002/ana.21050.
CAS Article PubMed PubMed Central Google Scholar
Dalmau J, Geis C, Graus F. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev. 2017;97:839–87. https://doi.org/10.1152/PHYSREV.00010.2016.
CAS Article PubMed PubMed Central Google Scholar
Kruger S, Ilmer M, Kobold S, Cadilha BL, Endres S, Ormanns S, et al. Advances in cancer immunotherapy 2019 - Latest trends. J Exp Clin Cancer Res. 2019; 38.https://doi.org/10.1186/s13046-019-1266-0
Vogrig A, Fouret M, Joubert B, Picard G, Rogemond V, Pinto AL, et al. Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors. Neurol Neuroimmunol NeuroInflammation. 2019;6: e604. https://doi.org/10.1212/NXI.0000000000000604. Relevant demonstration that immune checkpoint inhibitors are actually able to increase the frequency of paraneoplastic syndromes.
Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–40. https://doi.org/10.1136/jnnp.2003.034447.
CAS Article PubMed PubMed Central Google Scholar
Devine MF, Kothapalli N, Elkhooly M, and Dubey D. Paraneoplastic neurological syndromes: clinical presentations and management. Ther. Adv. Neurol. Disord. 2021; 14. https://doi.org/10.1177/1756286420985323. Excellent review on paraneoplastic neurological syndromes.
Sechi E, Flanagan EP. Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management. Front Neurol. 2021;12: 673339. https://doi.org/10.3389/fneur.2021.673339.
Article PubMed PubMed Central Google Scholar
Sabater L, Höftberger R, Boronat A, Saiz A, Dalmau J, Graus F. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. PLoS ONE. 2013;8: e60438. https://doi.org/10.1371/journal.pone.0060438.
CAS Article PubMed PubMed Central Google Scholar
Hardy-Werbin M, Arpí O, Taus A, Rocha P, Joseph-Pietras D, Nolan L, et al. Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab. Oncoimmunology 2018; 7. https://doi.org/10.1080/2162402X.2017.1395125.
Titulaer MJ, Klooster R, Potman M, Sabater L, Graus F, Hegeman IM, et al. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Oncol. 2009;27:4260–7. https://doi.org/10.1200/JCO.2008.20.6169.
CAS Article PubMed Google Scholar
Graus F, Dalmau J. Paraneoplastic neurological syndromes. Curr Opin Neurol. 2012;25:795–801. https://doi.org/10.1097/WCO.0b013e328359da15.
CAS Article PubMed PubMed Central Google Scholar
Zoccarato M, Gastaldi M, Zuliani L, Biagioli T, Brogi M, Bernardi G, et al. Diagnostics of paraneoplastic neurological syndromes. Neurol Sci. 2017;38:237–42. https://doi.org/10.1007/s10072-017-3031-5.
Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167–77. https://doi.org/10.1016/s1474-4422(13)70282-5.
CAS Article PubMed Google Scholar
Lancaster E, Lai M, Peng X, Hughes EG, Constantinescu R, Raizer J, et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67–9.
Gastaldi M, Mariotto S, Giannoccaro MP, Iorio R, Zoccarato M, Nosadini M, et al. Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study. Eur J Neurol. 2020;27:633–43. https://doi.org/10.1111/ene.14139.
CAS Article PubMed Google Scholar
McCracken L, Zhang J, Greene M, Crivaro A, Gonzalez J, Kamoun M, et al. Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol neuroinflammation. 2017;4: e404. https://doi.org/10.1212/nxi.0000000000000404.
Moll JWB, Vecht CJ, Henzen-Logmans SC, Van Der Burg MEL, Splinter TAW. Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system. J Neurol Neurosurg Psychiatry. 1990;53:940–3. https://doi.org/10.1136/jnnp.53.11.940.
CAS Article PubMed PubMed Central Google Scholar
Gastaldi M, Zardini E, Scaranzin S, Uccelli A, Andreetta F, Baggi F, et al. Autoantibody diagnostics in neuroimmunology: experience from the 2018 Italian Neuroimmunology Association External Quality Assessment Program. Front Neurol. 2019;10:1385. https://doi.org/10.3389/fneur.2019.01385.
Gorr T, Vogel J. Western blotting revisited: critical perusal of underappreciated technical issues. Proteomics - Clin Appl. 2015;9:396–405. https://doi.org/10.1002/prca.201400118.
CAS Article PubMed Google Scholar
Sabater L, Saiz A, Dalmau J, Graus F. Pitfalls in the detection of CV2 (CRMP5) antibodies. J Neuroimmunol. 2016;290:80–3. https://doi.org/10.1016/j.jneuroim.2015.11.009.
CAS Article PubMed Google Scholar
Budhram A, Nicolle MW, Yang L. The positive predictive value of onconeural antibody testing: a retrospective review. Can J Neurol Sci. 2018;45:577–9. https://doi.org/10.1017/cjn.2018.74.
Franciotta D, Gastaldi M, Biagioli T, Benedetti L, Giannotta C, Bedin R, et al. Anti-ganglioside antibodies: experience from the Italian Association of Neuroimmunology external quality assessment scheme. Clin Chem Lab Med. 2018;56:1921–5. https://doi.org/10.1515/cclm-2018-0234.
CAS Article PubMed Google Scholar
Déchelotte B, Muñiz-Castrillo S, Joubert B, Vogrig A, Picard G, Rogemond V, et al. Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflammation 2020; 7. https://doi.org/10.1212/NXI.0000000000000701.
Sabater L, Titulaer M, Saiz A, Verschuuren J, Güre AO, Graus F. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology. 2008;70:924–8. https://doi.org/10.1212/01.wnl.0000281663.81079.24.
CAS Article PubMed Google Scholar
Carvajal-Gonzalez A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain. 2014;137:2178–92. https://doi.org/10.1093/brain/awu142.
Article PubMed PubMed Central Google Scholar
Titulaer MJ, Lang B, Verschuuren JJGM. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10:1098–107. https://doi.org/10.1016/S1474-4422(11)70245-9.
Ruiz-García R, Muñoz-Sánchez G, Naranjo L, Guasp M, Sabater L, Saiz A, et al. Limitations of a commercial assay as diagnostic test of autoimmune encephalitis. Front Immunol 2021; 12. https://doi.org/10.3389/fimmu.2021.691536.
Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123:1481–94. https://doi.org/10.1093/brain/123.7.1481.
Dreessen J, Jeanjean AP, and Sindic CJM. Paraneoplastic limbic encephalitis: diagnostic relevance of CSF analysis and total body PET scanning. Acta Neurol Belg 2004; 104: 57–63.https://pubmed.ncbi.nlm.nih.gov/15508268/ (accessed 6 Oct 2021).
Dadparvar S, Anderson GS, Bhargava P, Guan L, Reich P, Alavi A, et al. Paraneoplastic encephalitis associated with cystic teratoma is detected by fluorodeoxyglucose positron emission tomography with negative magnetic resonance image findings. Clin Nucl Med. 2003;28:893–6. https://doi.org/10.1097/01.rlu.0000093284.54060.aa.
Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc. 2008;83:917–22. https://doi.org/10.4065/83.8.917.
Meglič B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci. 2001;185:135–8. https://doi.org/10.1016/S0022-510X(01)00467-1.
Graus F, Keime-Guibert F, Reñe R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138–48. https://doi.org/10.1093/brain/124.6.1138.
CAS Article PubMed Google Scholar
Bernal F, Shams’Ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology 2003; 60: 230–4. https://doi.org/10.1212/01.WNL.0000041495.87539.98.
Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments. Ann Neurol. 2003;53:580–7. https://doi.org/10.1002/ana.10518.
留言 (0)